September 11, 2024 Synerkine Pharma receives European Orphan Drug Designation for SK-01 to treat Complex Regional Pain Syndrome Read news release
September 2, 2024 Xintela signs agreement with Region Östergötland for GMP process development of cell therapy for burn patients Read news release
August 29, 2024 Nanologica resolves on a fully underwritten rights issue of units of approx. SEK 99.4 million, an over-allotment issue of up to SEK 20 million, and raises bridge loans of SEK 15 million Read news release
